These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 3827462)

  • 21. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
    Garcia HH; Gilman RH; Horton J; Martinez M; Herrera G; Altamirano J; Cuba JM; Rios-Saavedra N; Verastegui M; Boero J; Gonzalez AE
    Neurology; 1997 May; 48(5):1421-7. PubMed ID: 9153484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocysticercosis treated with praziquantel. Long-term follow-up of a case.
    Mancuso P; Chiaramonte I; Tropea R
    J Neurosurg Sci; 1991; 35(3):157-60. PubMed ID: 1774596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis.
    Rawlings D; Ferriero DM; Messing RO
    Neurology; 1989 May; 39(5):739-41. PubMed ID: 2710366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of praziquantel and albendazole in neurocysticercosis.
    Gupta R; Yadav NV
    J Assoc Physicians India; 1990 Apr; 38(4):313-4. PubMed ID: 2391343
    [No Abstract]   [Full Text] [Related]  

  • 27. Albendazole treatment of neurocysticercosis.
    Chotmongkol V
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):344-7. PubMed ID: 1439991
    [No Abstract]   [Full Text] [Related]  

  • 28. [Albendazole treatment in cerebral cysticercosis].
    Xiao ZX; Zhao CY; Liu YP
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):100-2, 127. PubMed ID: 3792122
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cerebral cysticercosis. Apropos of a case treated with praziquantel].
    Leger J; Bruguier A; Texier P; Diebler C; Ponsot G
    Arch Fr Pediatr; 1985; 42(6):451-3. PubMed ID: 4051677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The course of seizures after treatment for cerebral cysticercosis.
    Vazquez V; Sotelo J
    N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albendazole therapy in ring lesions of neurocysticercosis.
    Lowalekar KB
    J Assoc Physicians India; 1992 Oct; 40(10):694-6. PubMed ID: 1307363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albendazole treatment of multiple cerebral hydatid cysts: case report.
    Todorov T; Vutova K; Petkov D; Balkanski G
    Trans R Soc Trop Med Hyg; 1988; 82(1):150-2. PubMed ID: 3176143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous and cerebral cysticercosis treated with praziquantel.
    Quimosing EM; Conde J; Cross JH
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):201-5. PubMed ID: 6505787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.
    van Dellen JR; McKeown CP
    Neurosurgery; 1988 Jan; 22(1 Pt 1):92-6. PubMed ID: 3344093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral and subcutaneous cysticercosis treated with albendazole.
    Schmidt DK; Jordaan HF; Schneider JW; Cilliers J
    Int J Dermatol; 1995 Aug; 34(8):574-9. PubMed ID: 7591443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful treatment of cerebral cysticercosis with praziquantel].
    Nii Y; Nakagawa H; Taki T; Nakabayashi T
    No Shinkei Geka; 1988 Aug; 16(9):1083-8. PubMed ID: 3205370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
    Chagnon A; Galzin M; de Jaureguiberry JP; Boyer B; Paris JF; Marlier S; Carli P
    Med Trop (Mars); 1994; 54(3):275-6. PubMed ID: 7885211
    [No Abstract]   [Full Text] [Related]  

  • 39. Albendazole therapy for human neurocysticercosis, a controlled study with computerized tomography and magnetic resonance.
    Escobedo F; Sotelo J; Penagos P; Rodríguez J; del Bruto O
    Acta Leiden; 1989; 57(2):247-54. PubMed ID: 2489003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of neurocysticercosis.
    Joubert J; Jenni WK
    S Afr Med J; 1990 Jan; 77(1):27-30. PubMed ID: 2294609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.